Saturday 17 October 2026 Export NAMS’s income statement to Excel — free account

NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V.’s revenue for fiscal 2025 (year ended December 2025) was $22.5 million, down 50.6% from fiscal 2024. In the quarter to June 2026, revenue fell 80.7%, EPS fell 246.7% and free cash flow fell 4.07%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.83 0.79 −3.83%

Follow NAMS

Alert me

Market cap: $2.5B
P/E: 0.0×
Fwd P/E: −17.5×
Dividend yield: —
F-score: 3/9
Altman Z: 27.63
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	2	3	3	—	+8 more TTM periods Free account
ROE Full definition →	(36.81%)	(29.49%)	(28.29%)	(39.94%)
ROA Full definition →	(34.16%)	(27.43%)	(24.95%)	(36.08%)
ROIC Full definition →	0.00%	(484.09%)	(307.51%)	(532.55%)
Return on Tangible Assets Full definition →	(44.24%)	(36.00%)	(34.53%)	(32.78%)
Average Days of Receivables Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(1.16)	(1.17)	(1.25)	(1.21)
Free Cash Flow Full definition →	(143.72)	(142.19)	(148.03)	(144.54)
Capital Expenditures Full definition →	(0.26)	(0.27)	(0.25)	(0.15)
Other line items
Cash ROIC Full definition →	(11.35%)	(10.92%)	(11.21%)	(10.09%)
Accounts Receivable Turnover Full definition →	0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	2,095.87%	598.67%	630.28%	391.94%
Selling, General and Administrative Expense of Revenue Full definition →	1,436.33%	454.92%	472.62%	283.86%
Share Based Compensation of Revenue Full definition →	918.64%	275.71%	264.08%	155.54%
Operating CF/Net income Full definition →	0.55	0.67	0.73	0.65
Depreciation/Fixed assets Full definition →	0.59	0.61	0.57	0.66
Capex/Depreciation Full definition →	(1.07)	(1.17)	(1.12)	(0.70)
Revenue per Share Full definition →	0.06	0.19	0.19	0.30
Operating CF per Share Full definition →	(1.16)	(1.17)	(1.25)	(1.21)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.04	0.01	0.01	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly